CCR8 and keratosis pilaris: Thus, we examined the therapeutic potential of short-term VEGF blockade combined with antibody-mediated depletion of CCR8-expressing Treg cells, which represented only a fraction of intratumoral Treg cells in KP tumors (Fig. 8g).